Description
Description: Volantis is a medication available in tablet form, containing 5 milligrams of Everolimus as the active ingredient. Everolimus belongs to a class of medications known as mammalian target of rapamycin (mTOR) inhibitors and is used in the treatment of various types of cancer and certain non-cancerous conditions.
Indications: Volantis (Everolimus) is indicated for the treatment of several types of cancer, including advanced renal cell carcinoma (kidney cancer), advanced hormone receptor-positive, HER2-negative breast cancer, advanced pancreatic neuroendocrine tumors (pNET), and advanced gastrointestinal or lung neuroendocrine tumors (NET). Additionally, Everolimus may be prescribed for certain non-cancerous conditions such as tuberous sclerosis complex (TSC) and renal angiomyolipoma.
Mechanism of Action: Everolimus works by inhibiting the activity of the mTOR protein, which plays a key role in regulating cell growth, proliferation, and survival. By blocking mTOR signaling pathways, Everolimus helps slow down or inhibit the growth of cancer cells and the progression of certain non-cancerous conditions.
Administration: Volantis is administered orally in the form of tablets. The dosage and duration of treatment may vary depending on the specific type of cancer being treated, the patient’s overall health status, and response to therapy. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider.
Dosage and Treatment Plan: The recommended dosage of Volantis (Everolimus) will be determined by a healthcare provider based on individual patient factors and the specific type and stage of cancer or non-cancerous condition being treated. Treatment may involve taking Everolimus tablets once daily, with or without food, until disease progression or unacceptable toxicity occurs.
Side Effects: Common side effects associated with Volantis may include fatigue, nausea, diarrhea, stomatitis (mouth sores), rash, decreased appetite, and peripheral edema. More serious side effects may include infections, interstitial lung disease, renal failure, and metabolic abnormalities. It is essential to report any adverse reactions to a healthcare provider promptly.
Precautions:
- Volantis should be used with caution in patients with pre-existing medical conditions such as liver or kidney impairment, as well as those with a history of hypersensitivity to Everolimus or other mTOR inhibitors.
- It may interact with other medications, so it is important to inform the healthcare provider about all current medications, including over-the-counter drugs and supplements.
- Pregnant or breastfeeding women should avoid using Volantis, as it may harm the fetus or infant.
Consultation with a Healthcare Provider: Before starting treatment with Volantis (Everolimus), individuals should consult with a healthcare provider or qualified oncologist. They can provide guidance on proper usage, dosage, and potential risks associated with the medication. Regular monitoring and evaluation are essential to ensure safety and efficacy during treatment.
Reviews
There are no reviews yet.